Log In
Print
BCIQ
Print
Print this Print this
 

ND004

  Manage Alerts
Collapse Summary General Information
Company Numab AG
DescriptionAntibody blocking pain
Molecular Target Nav1.7 (SCN9A)
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody
Latest Stage of DevelopmentDiscovery
Standard IndicationPain
Indication DetailsTreat chronic and severe pain
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today